Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 4/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.44 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.44 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.42 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7885740 | 1.00 | OPRM1 (0.44) | OPRM1OPRK1OPRL1OPRD1SLC18A3 | |
| SCHEMBL7878654 | 1.00 | OPRM1 (0.44) | OPRM1OPRK1OPRL1OPRD1SLC18A3 | |
| SCHEMBL7885719 | 1.00 | OPRM1 (0.44) | OPRM1OPRK1OPRL1OPRD1SLC18A3 | |
| SCHEMBL7878638 | 1.00 | OPRM1 (0.44) | OPRM1OPRK1OPRL1OPRD1SLC18A3 | |
| SCHEMBL7887958 | 1.00 | OPRM1 (0.44) | OPRM1OPRK1OPRL1OPRD1SLC18A3 | |
| Hydrochloric Acid SCHEMBL7885454 | 0.99 | OPRL1 (0.44) | OPRM1OPRK1OPRL1OPRD1SLC18A3 | |
| Hydrochloric Acid SCHEMBL7885731 | 0.99 | OPRL1 (0.44) | OPRM1OPRK1OPRL1OPRD1SLC18A3 | |
| Hydrochloric Acid SCHEMBL7878772 | 0.99 | OPRL1 (0.44) | OPRM1OPRK1OPRL1OPRD1SLC18A3 | |
| Hydrochloric Acid SCHEMBL7878562 | 0.99 | OPRL1 (0.44) | OPRM1OPRK1OPRL1OPRD1SLC18A3 | |
| Hydrochloric Acid SCHEMBL7887960 | 0.99 | OPRL1 (0.44) | OPRM1OPRK1OPRL1OPRD1SLC18A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0970957-B1 | Diaza-spiro[3,5] nonane derivatives | HOFFMANN LA ROCHE (CH) | 2001-08-16 | — | — | EP | claimed |
| EP-0970957-A1 | Diaza-spiro[3,5] nonane derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2000-01-12 | — | — | EP | claimed |
| EP-0970957-B1 | Diaza-spiro[3,5] nonane derivatives | HOFFMANN LA ROCHE (CH) | 2001-08-16 | — | — | EP | disclosed |
| US-6113527-A | 3,3-BIS-HYDROXYMETHYL-7-(CIS-4-ISOPROPYL-CYCLOHEXYL)-1-PHENYL -1,7-DIAZA-SPIRO-(3.5)NONANE-2-ONE, FOR EXAMPLE; AGONISTS OF THE ORPHANIN FQ (OFQ) RECEPTOR; USEFUL IN THE TREATMENT OF PSYCHIATRIC, NEUROLOGICAL AND PHYSIOLOGICAL DISORDERS | HOFFMANN-LA ROCHE INC. (US) | 2000-09-05 | — | — | US | disclosed |
| EP-0970957-A1 | Diaza-spiro[3,5] nonane derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2000-01-12 | — | — | EP | disclosed |